Business
The Canadian company sold a record of $5.18 million in cannabis products last December
Hi, what are you looking for?
Mugglehead Investment Magazine
Earnings
Business
The firm says it's reformulated its concentrate lines to meet client expectations related to terpenes
Business
The firm is forecasting 2022 revenue of at least US$1.3B
Business
And 2022 is looking like a bright year for international medical cannabis markets
Business
But the company's CEO says it's already facing economic headwinds this year
Business
But the firm acknowledges a market slowdown in Q4 it was 'not immune to'
Business
Its majority shareholder Alcanna is set to be bought by Sundial for $346M at the end of March
Business
The firm says the charges give it a 'clean slate' for future growth
Business
The company continues to expand domestically and internationally
Business
The company says it expects revenue from capital expenditure projects to ramp up this year
